You are here

Eli Lilly

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

Could Novo, Lilly become first trillion-dollar healthcare companies?

Pharma Voice

Mon, 02/5/24 - 10:30 am

FDA website shows limited availability of some doses of Lilly's Mounjaro

Reuters

Mon, 02/5/24 - 10:12 am

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Pharmaceutical Business Review

Mon, 02/5/24 - 10:11 am

Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?

Motley Fool

Fri, 02/2/24 - 11:50 am

Lilly's weight-loss drug Mounjaro coming to UK after pen cleared

Reuters

Thu, 01/25/24 - 09:00 pm

Lilly's Mounjaro dose in limited availability in US through next month

Reuters

Wed, 01/24/24 - 11:39 pm

Lilly makes waves, says gene therapy restores hearing for child with genetic hearing loss

Fierce Biotech

Tue, 01/23/24 - 06:04 pm

Drugmakers explore muscle loss prevention when taking weight loss drugs

Beckers Hospital Review

Tue, 01/23/24 - 11:06 am

United States of Ozempic: Where anti-obesity drugs are taking off

Axios

Fri, 01/19/24 - 09:31 am

Eli Lilly’s Jaypirca to dominate CLL BTK inhibitor market by 2032

Biopharma Reporter

Thu, 01/18/24 - 05:04 pm

Researchers probe new uses of popular weight loss, diabetes drugs

Beckers Hospital Review

Tue, 01/16/24 - 09:08 am

JPM2024: Lilly CEO David Ricks Weighs In on GLP-1s and AI

BioSpace

Mon, 01/15/24 - 09:43 am

artificial intelligence

Roche is ‘on par’ with Novo, Lilly in GLP-1 race after $2.7B Carmot deal

Medical Devices and Diagnostics Industry

Fri, 01/12/24 - 11:33 am

GLP-1 agonist. obesity

FDA says no evidence yet linking weight loss drugs to suicidal thoughts

Reuters

Thu, 01/11/24 - 11:35 am

JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage

Medical Marketing and Media

Thu, 01/11/24 - 11:18 am

Zepbound shortage could be around the corner

Beckers Hospital Review

Tue, 01/9/24 - 10:05 pm

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM

Fierce Biotech

Sun, 01/7/24 - 04:19 pm

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

Reuters

Fri, 01/5/24 - 11:25 am

Bristol Myers Squibb

Carmot Therapeutics

Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss

Fierce Pharma

Thu, 01/4/24 - 11:53 am

Pages